Articles tagged with Pancreatitis
A team of scientists has identified a multi-step process where neutrophils are guided to specific tissue sites to confront infecting microbes or viruses. The study found that a signaling complex formed by TRPV2 and CB2R directs migration selectively toward sites of infection.
A major study reveals the incidence of acute pancreatitis in South Australia has increased to above the global average, with growth rates highest among women and those living in wealthier areas. The condition is increasingly linked to gallstones and metabolic risk factors, shifting the profile of who is at risk.
Researchers created a platform to study chronic pancreatitis pathogenesis and identify potential treatments by generating patient-derived organoids. The organoids revealed consistent dysfunction in the CFTR protein, which may be a future effective therapeutic target.
A new study found that chronic pancreatitis (CP) impairs multiple quality-of-life domains, including mobility, self-care, daily activities, mental health, and pain. Employment status is a powerful protective factor, while older age correlates with milder QoL impairments.
Researchers highlight latest developments in pathology, diagnosis, and treatment of MASLD and IPFD, revealing correlations with chronic diseases like liver cancer and pancreatic cancer. Innovative treatments, such as AI-driven approaches and organ-targeted therapies, show promise for precision prevention and therapy.
A study identified alterations in the endocannabinoid system associated with severe acute pancreatitis, including decreased circulating levels of 2-AG. Restoring 2-AG levels reduced inflammation and lung damage, highlighting the system's role in the disease's pathophysiology.
Researchers found that Rhein reduces pancreatic and intestinal damage, restores intestinal barrier integrity, and promotes repair macrophage responses. PPARγ is identified as the central mediator of Rhein's effects.
A randomized clinical study found that adding a fungal probiotic to standard enteral nutrition reduced nosocomial infections in critically ill patients with severe pancreatitis. The intervention also stabilized intestinal and respiratory microbiota, highlighting the potential of microbiome-targeted therapies. Fungal probiotics may offe...
A new study found that while the number of pancreatitis-associated deaths among the elderly decreased between 1992 and 2021, the total cases rose significantly due to population growth. The age-standardized incidence rate per 100,000 fell from 100.21 in 1992 to 85.20 in 2021.
Recent research highlights advances in precision medicine and multidisciplinary management for pancreatitis, including improved fluid resuscitation strategies and novel molecular therapies. Gene-based treatments like SPINK1 gene therapy show promise in reversing fibrosis and improving quality of life for patients.
A new genetic test developed at Mayo Clinic is redefining how clinicians diagnose and manage hereditary pancreatitis. The test includes nine genes and uses whole exome sequencing to analyze coding regions, providing comprehensive analysis of disease-causing genes.
Catherine Whittington, a WPI researcher, has received a CAREER Award to develop laboratory models for the study of fibrosis in pancreas, skin, and uterine fibroids. The models will help researchers better understand factors at the cellular level that lead to fibrosis and how interventions can interrupt or reverse it.
A UNLV study uses an mRNA cocktail to selectively route to the pancreas, reducing the risk of immune responses and side effects. The breakthrough offers new hope for treating pancreas-related diseases, including cancer and diabetes.
Excessive alcohol consumption causes severe digestive problems, including liver damage, stomach disorders, and increased cancer risk. Chronic alcohol use can lead to conditions like cirrhosis, pancreatitis, and colorectal cancer.
Researchers at the University of Malaga have identified multiple genetic variants causing Familial Chilomicronemia Syndrome, a rare disease characterized by high triglyceride levels. This discovery enables accurate clinical diagnosis and treatment selection for patients with this condition.
A recent study published in Nature Medicine analyzed over 2 million veterans taking GLP-1RA medications, finding benefits to cognitive and behavioral health while revealing increased risks for pancreatitis and kidney conditions. The study also showed decreased risks of seizures, addiction, suicidal ideation, and neurocognitive disorders.
Researchers developed a prediction model for infected pancreatic necrosis (IPN) in acute pancreatitis patients, identifying high-risk individuals within 24 hours of hospital admission. The model achieved an area under the receiver operating characteristic curve (AUC) of 0.85, outperforming widely used scoring systems.
Researchers discovered that vitamin B12 reduces the risk of developing different types of pancreatitis by strongly associating with reduced risk. Vitamin B12 also displays protective effects on acinar cells from necrosis during early stages of acute pancreatitis and promotes tissue repair.
This study elucidates the elements of immune system responses that induce and maintain autoimmune pancreatitis. The researchers found that plasmacytoid dendritic cells producing IFN-α and IL-33 drive AIP in murine models, with depletion or inhibition of these pathways inhibiting disease development.
A large-scale population analysis confirms tirzepatide's similar gastrointestinal tolerability to other GLP-1 medications without increased risk of diabetic retinopathy, medullary thyroid cancer, or pancreatitis. Researchers analyzed real-world evidence from the FDA adverse event reporting system database and found that tirzepatide has...
Researchers developed an antioxidant gel to preserve islet function after pancreas removal, significantly improving survival and preserving normal blood sugar levels in animals. The new approach could enable patients to live pain-free without complications of diabetes.
Defective autophagy in pancreatitis allows damaged organelles to accumulate, disrupting cellular function and potentially leading to cell death. Researchers identified therapeutic targets within the autophagy pathway, including VMP1 and TFEB.
A retrospective cohort study found that PERT significantly reduced the incidence of acute pancreatitis episodes among children with recurrent or chronic pancreatitis. The study also identified genetic markers, such as SPINK1 mutation, that influence treatment outcomes and suggest a tailored approach to patient care.
A new study by Flinders University highlights the need for targeted clinical research to reduce prolonged hospital stays and mortality rates in patients with severe acute pancreatitis. Despite improvements in survival rates, the disease remains a major concern, particularly in high-income countries.
Researchers identify SRSF1 as a key player in promoting pancreatitis and pancreatic cancer growth. High levels of SRSF1 are associated with worse patient outcomes, highlighting its potential as a target for new therapies.
Researchers have found a possible early warning indicator for adverse reactions to childhood cancer treatments. Low levels of vitamin A in the liver and blood may signal an increased risk of pancreatitis, a potentially life-threatening complication of asparaginase treatment. Increasing dietary vitamin A levels may help reduce this risk.
Researchers found that consuming vitamin A or its analogs can help prevent painful pancreas inflammation in children and young adults with acute lymphoblastic leukemia (ALL) during chemotherapy treatment. The study revealed that only 1.4% of patients developed pancreatitis when taking vitamin A, compared to 3.4% without it.
A phase 2 study found that ANGPTL3 inhibitor therapy reduced triglycerides by up to 70% in patients with severe hypertriglyceridemia who had previously experienced acute pancreatitis. The treatment, evicanumab-dgnb, also showed potential for cardiovascular prevention by reducing apolipoprotein B levels.
Researchers found that COVID-19 infections are linked to an increased risk of developing liver problems, acute pancreatitis, and other GI disorders. The study analyzed over 14 million medical records and estimated that SARS-CoV-2 infections have contributed to over 6 million new cases of GI disorders in the US.
A large study on chronic pancreatitis patients who underwent surgery found that about two-thirds survive for 10 years, but over a quarter struggle with persistent opioid use. Long-term follow-up revealed significant psychosocial issues, including substance abuse, narcotics abuse, and end-stage liver disease.
A new study by Cedars-Sinai investigators has identified risk factors for developing diabetes in people with chronic pancreatitis, including smoking and being overweight. The findings suggest that models can be built to predict diabetes risk, allowing clinicians to connect patients with weight loss or smoking cessation programs.
Researchers found that visceral artery pseudoaneurysms in necrotizing pancreatitis are associated with significant morbidity and mortality. The study also highlighted the importance of early detection and treatment, as delayed diagnosis can lead to increased complications and mortality.
Researchers identified estrogen-related receptor gamma (ERR γ) as crucial for preventing pancreatic auto-digestion in mice. In humans, lower levels of ERR γ were found in cells affected by pancreatitis. These findings suggest new therapies regulating ERR γ activity could help prevent or treat these conditions.
A multicenter study found relatively high interobserver agreement for chronic pancreatitis findings in children using both CT and MRI. However, subjective findings like atrophy showed moderate agreement, emphasizing the need for standardized criteria.
A new review suggests that moderate coffee consumption can stimulate digestive processes and help movement through the colon. The study also found a possible association between coffee consumption and reduced risk of gallstones and certain liver diseases. However, further research is needed to confirm these findings.
Chronic pancreatitis is a debilitating disease with poorly understood causative factors. Researchers at Osaka University identified disturbed molecular pathways and revealed underlying mechanisms that may inform effective therapy against the disease.
In a phase 2 trial, evinacumab significantly reduced triglyceride levels in patients with severe hypertriglyceridemia, particularly those with specific genetic mutations. The study found that the magnitude of response was highly dependent on the participant's genetic profile.
Evinacumab reduces triglyceride levels by up to 82 percent in patients with severe hypertriglyceridemia and a history of hospitalizations for acute pancreatitis. The therapy also lowers the risk of recurrent acute pancreatitis, quality of life, and cardiovascular events.
This study validates the significance of two critical thresholds in pancreatitis, one for damage to acinar cells and another for clinical symptoms. It highlights the importance of cost transparency, preoperative informed financial consent, and price regulation to reduce financial hardship faced by patients and their families.
A study published in Gastroenterology identified a genetic defect in the calcium channel TRPV6 as a cause of early-onset chronic pancreatitis. The researchers found that the absence of this gene led to inflammation and fibrotic changes in the pancreas, paving the way for new therapeutic interventions.
Researchers at Salk Institute discover formation of tuft cells during pancreatitis, which secrete IL-25 to promote immune response. The finding may lead to development of new treatments for pancreatitis and pancreatic cancer.
A Mayo Clinic-led study reveals that rapid fat degradation occurs in acute pancreatitis, triggered by PNLIP enzyme, and worsens disease outcomes. Obesity exacerbates pancreatitis risk, while unsaturated fats increase organ failure risk.
Studies in mice and humans with pancreatitis reveal a link between FGF21 deficiency and the disease. Replacement therapy with FGF21 may reverse conditions in about 24 hours, offering a new treatment strategy for acute pancreatitis.
A new study published in the Obesity journal found that adolescents and teens experience biliary side effects after weight-loss surgery at a rate similar to adults. Pediatric patients are more likely to manifest symptoms as pancreatic inflammation or acute pancreatitis, whereas adults are more likely to develop gallbladder issues.
Researchers discovered that CA19-9, a complex sugar molecule, causes pancreatitis by recruiting the immune system and inducing deleterious biochemical reactions. Targeting CA19-9 with antibodies may prevent or treat pancreatitis and its progression to pancreatic cancer.
A gene therapy case report published in Human Gene Therapy reveals a safe and effective treatment for lipoprotein lipase deficiency, with improved quality of life outcomes after discontinuing plasmapheresis. The treatment, ali-pogene tiparvovec, has been approved in Europe to treat the rare inherited disorder.
Researchers found a significant link between pancreatitis in minority populations and severe levels of triglycerides, as well as gallstones and excessive alcohol intake. The study's findings may help physicians assess the risk of pancreatitis and develop early detection strategies.
The American Gastroenterological Association's new clinical guideline focuses on critical decisions made during initial management of acute pancreatitis. It recommends goal-directed fluid resuscitation, early oral feeding, and enteral versus parenteral nutrition to alter the course of disease and duration of hospitalization.
A new study suggests that early solid or tube feeding can lead to fewer symptoms, shorter hospital stays, and similar risk outcomes for patients with mild pancreatitis. However, the evidence for patients with severe disease was weak, but still did not show harm.
A study published in The Journal of Pediatrics suggests that genetic mutations and family history are common risk factors for children diagnosed with acute recurrent and chronic pancreatitis before age 6. Researchers analyzed 342 children and found that 71% had at least one pancreatitis-associated gene mutation.
Seventy percent of patients who kept their gallbladders despite experiencing biliary pancreatitis had no recurrence four years later. A large database analysis found that many patients who did not undergo surgery within 30 days still had no recurrences over a four-year follow-up period.
Research reveals a significant link between elevated blood fats and acute pancreatitis, with even mild increases posing a ninefold greater risk. The study's findings highlight the need for further research into the role of common fats in disease development.
A new procedure using a 22-gauge needle improves the diagnosis of autoimmune pancreatitis (AIP) through microscopic examination of tissue samples. Researchers successfully diagnosed AIP in 58% of patients using this method, offering a solution for distinguishing AIP from pancreatic cancer.
Recent CMGH articles suggest that targeting gut microbial populations may help prevent or treat Crohn's disease. A new study also identifies a potential therapy for chronic pancreatitis by reducing fibrosis and damage to the pancreas.
Researchers identified a rare genetic variation associated with an increased risk of severe acute pancreatitis in ALL patients treated with asparaginase. Native American ancestry and older age were also found to be risk factors for the condition.
Researchers discovered that all four parts of the IP3 receptor must be activated for calcium to increase and initiate fluid secretion. This finding has broad implications for understanding human secretory disorders like Sjögren's syndrome, which causes dry mouth and affects quality of life.
Researchers at the University of Edinburgh have identified a chemical compound that blocks KMO, fueling inflammation linked to acute pancreatitis. The approach calms inflammation in the condition and protects against organ failure, offering hope for patients with life-threatening complications.
Two studies found that recurrent acute and chronic pancreatitis in children has a high disease burden, with 42% rate of rehospitalizations and estimated annual healthcare costs of $40,000. The studies highlight the need for information and research to prevent suffering and reduce costs.
Researchers at MUSC are exploring a new treatment for chronic pancreatitis using Alpha 1 anti-trypsin (AAT), which has shown promise in preventing diabetes and improving liver implantation. The study aims to examine the effects of AAT on human islets in patients with pancreatic cancer.
A University of Eastern Finland study found that small gallstones are often caused by idiopathic pancreatitis and can be prevented by laparoscopic gallbladder removal surgery. Statin use was also associated with an increased risk of acute pancreatitis, especially during the first year of use.